The IQA Energy Partition in a Drug Design Setting: A Hepatitis C Virus RNA-Dependent RNA Polymerase (NS5B) Case Study

被引:2
|
作者
Zapata-Acevedo, Cesar A. [1 ,2 ,3 ]
Popelier, Paul L. A. [1 ]
机构
[1] Univ Manchester, Dept Chem, Oxford Rd, Manchester M13 9PL, Lancs, England
[2] Univ Nacl Autonoma Mexico, Inst Quim, Circuito Exterior S-N,Ciudad Univ, Ciudad De Mexico 04510, Mexico
[3] Tecnol Monterrey, Campus Santa Fe,Av Carlos Lazo 100, Ciudad De Mexico 01389, Mexico
基金
英国工程与自然科学研究理事会;
关键词
interacting quantum atoms; quantum chemical topology; quantum theory of atoms in molecules; fragment-based drug design; NS5B; hepatitis C virus; relative energy gradient method; INTERACTING QUANTUM ATOMS; HCVNS5B POLYMERASE; DISCOVERY; INHIBITORS; SITE;
D O I
10.3390/ph15101237
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The interaction of the thumb site II of the NS5B protein of hepatitis C virus and a pair of drug candidates was studied using a topological energy decomposition method called interacting quantum atoms (IQA). The atomic energies were then processed by the relative energy gradient (REG) method, which extracts chemical insight by computation based on minimal assumptions. REG reveals the most important IQA energy contributions, by atom and energy type (electrostatics, sterics, and exchange-correlation), that are responsible for the behaviour of the whole system, systematically from a short-range ligand-pocket interaction until a distance of approximately 22 angstrom. The degree of covalency in various key interatomic interactions can be quantified. No exchange-correlation contribution is responsible for the changes in the energy profile of both pocket-ligand systems investigated in the ligand-pocket distances equal to or greater than that of the global minimum. Regarding the hydrogen bonds in the system, a "neighbour effect" was observed thanks to the REG method, which states that a carbon atom would rather not have its covalent neighbour oxygen form a hydrogen bond. The combination of IQA and REG enables the automatic identification of the pharmacophore in the ligands. The coarser Interacting Quantum Fragments (IQF) enables the determination of which amino acids of the pocket contribute most to the binding and the type of energy of said binding. This work is an example of the contribution topological energy decomposition methods can make to fragment-based drug design.
引用
收藏
页数:34
相关论文
共 50 条
  • [21] Nucleoside, Nucleotide, and Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-Dependent RNA-Polymerase
    Sofia, Michael J.
    Chang, Wonsuk
    Furman, Phillip A.
    Mosley, Ralph T.
    Ross, Bruce S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (06) : 2481 - 2531
  • [22] Discovery of α,γ-diketo acids as potent selective and reversible inhibitors of hepatitis C virus NS5b RNA-dependent RNA polymerase
    Summa, V
    Petrocchi, A
    Pace, P
    Matassa, VG
    De Francesco, R
    Altamura, S
    Tomei, L
    Koch, U
    Neuner, P
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (01) : 14 - 17
  • [23] Hepatitis C Virus RNA Replication Requires a Conserved Structural Motif within the Transmembrane Domain of the NS5B RNA-Dependent RNA Polymerase
    Brass, Volker
    Gouttenoire, Jerome
    Wahl, Anja
    Pal, Zsuzsanna
    Blum, Hubert E.
    Penin, Francois
    Moradpour, Darius
    JOURNAL OF VIROLOGY, 2010, 84 (21) : 11580 - 11584
  • [24] RETRACTED: Oligomeric interaction of hepatitis C virus NS5B is critical for catalytic activity of RNA-dependent RNA polymerase (Retracted Article)
    Qin, WP
    Luo, H
    Nomura, T
    Hayashi, N
    Yamashita, T
    Murakami, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (03) : 2132 - 2137
  • [25] Novel 4-Thiazolidinones as Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-Dependent RNA Polymerase
    Cakir, Gizem
    Kucukguzel, Ilkay
    Guhamazumder, Rupa
    Tatar, Esra
    Manvar, Dinesh
    Basu, Amartya
    Patel, Bhargav A.
    Zia, Javairia
    Talele, Tanaji T.
    Kaushik-Basu, Neerja
    ARCHIV DER PHARMAZIE, 2015, 348 (01) : 10 - 22
  • [26] RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region
    Yamashita, T
    Kaneko, S
    Shirota, Y
    Qin, WP
    Nomura, T
    Kobayashi, K
    Murakami, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (25) : 15479 - 15486
  • [27] A cis-acting replication element in the sequence encoding the NS5B RNA-dependent RNA polymerase is required for hepatitis C virus RNA replication
    You, SY
    Stump, DD
    Branch, AD
    Rice, CM
    JOURNAL OF VIROLOGY, 2004, 78 (03) : 1352 - 1366
  • [28] NS5B RNA Dependent RNA Polymerase Inhibitors: The Promising Approach to Treat Hepatitis C Virus Infections
    Deore, R. R.
    Chern, J. -W.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (32) : 3806 - 3826
  • [29] Episodic adaptive diversification of classical swine fever virus RNA-dependent RNA polymerase NS5B
    Li, Yan
    Yang, Zexiao
    CANADIAN JOURNAL OF MICROBIOLOGY, 2015, 61 (12) : 948 - 954
  • [30] Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase
    De Francesco, R
    Tomei, L
    Altamura, S
    Summa, V
    Migliaccio, G
    ANTIVIRAL RESEARCH, 2003, 58 (01) : 1 - 16